PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising progress throughout numerous health-related and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, much more dependable different for therapeutic use,